Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-25-000836
Filing Date
2025-01-03
Accepted
2025-01-03 16:40:45
Documents
2
Period of Report
2025-01-01

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm251877-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm251877-1_4seq1.xml 4 7670
2 EXHIBIT 24 tm251877d1_ex24.htm EX-24 8837
  Complete submission text file 0001104659-25-000836.txt   18181
Mailing Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878
Business Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878 2406541450
Altimmune, Inc. (Issuer) CIK: 0001326190 (see all company filings)

EIN.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address ALTIMMUNE, INC. 910 CLOPPER ROAD, SUITE 201S GAITHERSBURG MD 20878
Business Address
Jordt Raymond M (Reporting) CIK: 0001960780 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32587 | Film No.: 25507156